ecrin-mdr-crcClinical2023Colorectal CancerColorectal NeoplasmsSolid TumorsColorectal CancerColorectal NeoplasmsSolid TumorsInterventionalhttps://newmdr.ecrin.org/Study/8638United States4SNDX-5613RevumenibMeninECRIN MDRRecruitingfalseEvaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid TumorsThis study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of SNDX-5613 in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.2023-04-158638NCT05731947